Bank of Montreal’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-26,600
Closed -$2.56M – 3914
2025
Q4
$2.56M Sell
26,600
-13,400
-34% -$1.3M ﹤0.01% 1564
2025
Q3
$3.81M Hold
40,000
– – ﹤0.01% 1419
2025
Q2
$3.49M Hold
40,000
– – ﹤0.01% 1389
2025
Q1
$3.59M Buy
+40,000
New +$3.58M ﹤0.01% 1291
2020
Q3
– Sell
-84,800
Closed -$7.64M – 4863
2020
Q2
$7.64M Buy
+84,800
New +$8.13M 0.01% 968
2020
Q1
– Sell
-268,100
Closed -$30.4M – 4446
2019
Q4
$30.4M Buy
+268,100
New +$29.4M 0.02% 559
2019
Q2
– Sell
-58,300
Closed -$5.31M – 5001
2019
Q1
$5.31M Buy
58,300
+44,600
+326% +$3.99M ﹤0.01% 1129
2018
Q4
$1.25M Sell
13,700
-636,300
-98% -$59.5M ﹤0.01% 1783
2018
Q3
$63.9M Buy
+650,000
New +$60.1M 0.05% 314

Other funds holding MDT

Bank of Montreal's MDT Position: Q2 2026 in Review

Bank of Montreal reduced its Medtronic (MDT) stake by 3.3% in Q2 2026, selling an estimated $10.4M and leaving 3,765,229 shares worth $295M. The position accounts for 0.1% of the portfolio, ranked #165.

Bank of Montreal first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $587M in Q4 2020. 2,147 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Bank of Montreal held 3,765,229 shares of Medtronic worth $295M as of Q2 2026.
  • Bank of Montreal sold 128,558 Medtronic shares in Q2 2026, an estimated $10.4M.
  • Medtronic made up 0.1% of Bank of Montreal's portfolio in Q2 2026, its #165 holding.
  • Bank of Montreal first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
  • Bank of Montreal's Medtronic position peaked at $587M in Q4 2020.
  • 2,147 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.